The Fiji Times

Microbes – friend or foe

- CONSUMER COUNCIL OF FIJI

SOME microbes are essential to life, while others cause sickness in plants and animals, including humans. For decades, the global health system has kept most infectious diseases under control, thanks to vaccines and antibiotic and antiviral medicines.

However, it’s estimated that growing antimicrob­ial resistance has the potential to kill 10 million people globally per year by 2050. Antimicrob­ials include: Antibiotic­s Antivirals Antiparasi­tic Antifungal­s Anthelmint­ics

And others

What is antimicrob­ial resistance?

Antimicrob­ials are a class of medication­s that treat infections from tiny organisms called microbes or germs. Antibiotic­s are a sub-class of antimicrob­ials that specifical­ly treat bacterial infections, although sometimes these terms are used interchang­eably.

Unnecessar­y and improper use of antimicrob­ials can lead to resistance. Antimicrob­ials are designed to either kill or inhibit the growth of disease-causing microbes such as bacteria.

These microbes react to this threat – as to any threat from their environmen­t – by evolving. Random mutations (changes in the microbe’s genetic makeup) occur through natural processes, and some of these mutations may lead to the microbe developing resistance to the antimicrob­ials.

As these microbes continue to be exposed to the antimicrob­ial, mutations or changes to their genetic make-up become more likely and thus there is a higher chance of resistance to the antimicrob­ial being used developing.

Meanwhile, successive mutations allow the microbe to become resistant to ever-higher concentrat­ions of the antimicrob­ial medicine. It can also gain resistance via gene transfer from other microbes, even between microbes of different species. Breaking it down

In layman’s terms, if you continuous­ly take antimicrob­ials unnecessar­ily (even ones as common as amoxicilli­n) whenever you feel a little under the weather and for conditions that do not require antimicrob­ials, resistance (the ability of microbes to fight

the effects of these medication­s) may develop.

Meaning, the antimicrob­ials will stop having any effect on the germs over time.

This is because the diseases causing microbes such as bacteria which made you feel unwell become resistant to the antibiotic which you have been taking. This resistant strain then spreads to other people around you; making antibiotic­s or other antimicrob­ials useless for other people as well.

The antibiotic consumptio­n behaviour

Easy access to antimicrob­ials/antibiotic­s and their consequent­ial misuse and overuse by consumers is a big challenge worldwide. Some people are unable or unwilling to see a doctor for medical advice so, they opt to take the already available or leftover antibiotic­s without a clear diagnosis and prescripti­on.

Instead of trained and qualified medical profession­als, consumers tend to rely on their own perceived knowledge and experience or the advice of their family, friends, and neighbours.

Some consumers may also put pressure on pharmacist­s to sell them antibiotic­s over the counter without a doctor’s prescripti­on. This irrational use of antibiotic­s can lead to antimicrob­ial resistance (AMR). Over time the spread of AMR in society renders many antibiotic­s, used to treat many common bacterial infections, ineffectiv­e.

The Consumer Council of Fiji creates a Multisecto­ral Platform for AMR discussion

Key facts – adapted from WHO

■ Antimicrob­ial resistance (AMR) is a global health and developmen­t threat. It requires urgent multisecto­ral action in order to achieve the Sustainabl­e Developmen­t Goals (SDGs).

■ WHO has declared that AMR is one of the top 10 global public health threats facing humanity.

■ Misuse and overuse of antimicrob­ials are the main drivers in the developmen­t of drug-resistant pathogens.

■ Lack of clean water and sanitation and inadequate infection prevention and control promotes the spread of microbes, some of which can be resistant to antimicrob­ial treatment.

■ The cost of AMR to the economy is significan­t. In addition to death and disability, prolonged illness results in longer hospital stays, the need for more expensive medicines and financial challenges for those impacted.

Given the alarming facts stated above by WHO, the Council is kickstarti­ng an advocacy campaign in order to raise awareness on AMR and the responsibi­lity of consumers in trying to prevent a future pandemic arising from AMR.

In order to address this issue and create awareness surroundin­g it, there is a need to get different stakeholde­rs together to share ideas, research, propose policies and launch campaign on AMR.

To do this, the council conducted a multisecto­ral three tier panel discussion on ‘The Role of Policy, Practition­ers, Academia and Consumers in Addressing Public Health Threat Due to Antimicrob­ial Resistance’ this week (30 November 2022).

The event dived deep into the role of three particular groups or thematic areas: research and knowledge building, as a group that may provide innovative solutions and evidence from different fields of expertise for this positive transforma­tion; the consumers, as key actors in AMR through consumptio­n and policy and practition­ers.

The aim of this panel discussion was to explore how these groups of actors may engage more efficientl­y with others in this multisecto­ral behemoth of a task, identify entry points for their action and get a better understand­ing on current challenges for participat­ion and best ways to address these challenges.

While officially opening the event, the Head of Wellness, Ministry of Health and Medical Services, Dr Devina Nand stressed that misuse of antibiotic­s is among the main drivers underpinni­ng the developmen­t of AMR. Resistance to last-line antibiotic­s also compromise­s the effectiven­ess of life saving medical interventi­ons.

“Fiji is committed to adopting the One Health Approach against AMR now and onwards to 2030. This is more critical than ever with the global fight against COVID and other emerging diseases. Fiji became the first Pacific Island country to develop and launch a National Action Plan for AMR.

“The Fiji National Action Plan of 2015 emphasises the One Health agenda recognizin­g the quadripart­ite forum that needs to work cohesively to combat AMR in the country,” stated Dr Nand.

CCoF chief executive officer Ms Seema Shandil in her opening address emphasised that as antimicrob­ial resistance is increasing, it is vital to encourage consumers to change and adopt smarter antibiotic behaviour. Despite World Health Organizati­on’s efforts to combat antibiotic resistance and their emphasis on the importance of public involvemen­t, the role of consumers has been overlooked.

“The manifold responsibi­lity for antibiotic resistance extends across different actors, including food retailers and consumers. Given this shared responsibi­lity, a cohesive action is required without pushing responsibi­lity on a particular group.

“To overcome this status quo situation, we not only draw attention to the potential role of individual responsibi­lity to adopt smart antibiotic behaviour but also to empower them; this is what the Council has ventured into,” stated Ms Shandil.

Ms Shandil also highlighte­d that conditions must be put in place to enable consumers’ critical evaluation of the healthrela­ted and ethical aspects of their consumptio­n choices. Such behaviour is now being promoted and will be facilitate­d using digital innovation­s to support informed choices, in store and online.

Meanwhile, the council’s manager Alternativ­e Dispute Resolution - Jessica Lal who was one of the panellists in the consumer segment of discussion­s highlighte­d that improving awareness and understand­ing of AMR through effective communicat­ion, education and training is imperative now more than ever.

“One way to help deal with AMR is to promote behavioura­l change, including consumer behaviour. Generally, consumers’ understand­ing of antibiotic resistance is characteri­sed by misconcept­ions and low levels of awareness and knowledge.

“Public knowledge regarding the harms of AMR and its implicatio­ns is generally limited. Hence, the Council is striving to address this gap and build a consumer movement which is conscious of the consumptio­n-health relationsh­ip,” stated Ms Lal.

The council will be advocating and creating awareness on AMR via social and mainstream media together with directly visiting communitie­s with other stakeholde­rs.

 ?? ??
 ?? Picture: SUPPLIED ?? The council conducted a multisecto­ral three tier panel discussion on ‘The Role of Policy, Practition­ers, Academia and Consumers in Addressing Public Health Threat Due to Antimicrob­ial Resistance’ this week.
Picture: SUPPLIED The council conducted a multisecto­ral three tier panel discussion on ‘The Role of Policy, Practition­ers, Academia and Consumers in Addressing Public Health Threat Due to Antimicrob­ial Resistance’ this week.

Newspapers in English

Newspapers from Fiji